Diagnostic Performance of Precore Protein 22 Kilodalton Levels of HBV DNA in Chronic Hepatitis B Patients
DOI:
https://doi.org/10.24293/ijcpml.v29i3.2020Keywords:
Chronic hepatitis B, HBV DNA, p22crAbstract
Hepatitis B Virus (HBV) infection causes inflammation of the liver, which has a high prevalence in both Indonesia and the world. Serum HBV deoxyribonucleic acid (DNA) is important in determining the initiation therapy for Chronic Hepatitis B (CHB) patients. However, it has several limitations. Precore protein 22 kilodalton (p22cr) is synthesized from the HBV gene in hepatocytes, representing covalently closed circle (ccc) DNA. This study aimed to analyze the diagnostic performance of p22cr levels on HBV DNA in CHB patients. An observational analytic study with a cross-sectional approach was conducted on 83 CHB patients who were examined at the Clinical Pathology Laboratory of Dr. Moewardi General Academic Hospital in December 2020. Blood plasma samples were taken for HBV DNA and p22cr examination by using Polymerase Chain Reaction (PCR) and Enzyme-Linked Immunosorbent Assay (ELISA), respectively. The cut-off level of p22cr was determined by the Receiver Operating Curve (ROC) with the widest area Under the Curve (AUC). Sensitivity, specificity, Positive Predictive Value (PPV), Negative Predictive Value (NPV), Positive Likelihood Ratio (PLR), Negative Likelihood Ratio (NLR), and accuracy were calculated for the diagnostic performance of p22cr. The cut-off point of p22cr on HBV DNA > 20,000 IU/mL was 7.440 ng/mL with AUC 0.693 (p=0.003). The diagnostic performance of p22cr levels on HBV DNA obtained 44.44% sensitivity, 82.98% specificity, 66.67% PPV, 66.10% NPV, 2.61 PLR, 0.67 NLR, and 66.27% accuracy. P22cr level has a good specificity so it can be an alternative examination of HBV DNA in making decisions on therapy in patients with chronic hepatitis B. Further research needs to be done using HBcrAg and excluding elderly patients.
Downloads
References
Sarin SK, Kumar M, Lau GK, Abbas Z, Chan HL, et al. Asian-Pacific clinical practice guidelines on the management of hepatitis B: A 2015 update. Hepatology International, 2016; 10(1): 1-98.
Pellicoro A, Ramachandran P, Iredale JP, Fallowfield JA. Liver fibrosis and repair: Immune regulation of wound healing in a solid organ. Nature Reviews Immunology, 2014; 14(3): 181-94.
World Health Organization. Guidelines for the prevention, care, and treatment of persons with chronic hepatitis B infection. Geneva, Switzerland, World Health Organization, 2015; 36-37.
Kemenkes. Riset Kesehatan Dasar (Riskesdas). Jakarta, Balitbang Kemenkes RI, 2013; 71-75.
Kemenkes. Riset Kesehatan Dasar (Riskesdas). Jakarta, Balitbang Kemenkes RI, 2018; 89-91.
Jackson K, Locarnini S, Gish R. Diagnostics of hepatitis B virus: Standard of care and investigational. Clin Liver Dis, 2018; 12(1): 5-11.
Wang X, Chi X, Wu R, Xu H, Gao X, et al. Serum HBV RNA correlated with intrahepatic cccDNA more strongly than other HBV markers during peg-interferon treatment. Virol J, 2021; 18(1): 4.
Inoue T, Tanaka Y. The role of hepatitis B core-related antigen. Genes (Basel), 2019; 10(5): 357.
Wu JW, Kao JH, Tseng TC. Three heads are better than two: Hepatitis B core-related antigen as a new predictor of hepatitis B virus-related hepatocellular carcinoma. Clin Mol Hepatol, 2021; 27(4): 524-534.
European Association for the study of the liver. EASL 2017 clinical practice guidelines on the management of hepatitis B virus infection. J Hepatol, 2017; 67(2): 370- 398.
Dahlan MS. Besar sampel dan cara pengambilan sampel dalam penelitian kedokteran dan kesehatan. Jakarta, Salemba Medika, 2010; 85-90.
Muljono DH. Epidemiology of hepatitis B and C in Republic of Indonesia. Euroasian J Hepatogastroenterol, 2017; 7(1): 55-59.
Centers for Disease Control and Prevention (CDC). Hepatitis B information. 2020 Available at: https://www.cdc.gov/hepatitis/hbv/index.htm (accessed Dec 21, 2020).
Ie SI, Turyadi, Sidarta E, Sadhewa A, Purnomo GA, et al. High prevalence of hepatitis B virus infection in young adults in Ternate, Eastern Indonesia. Am J Trop Med Hyg, 2015; 93(6): 1349–1355.
Burns GS, Thompson AJ. Viral hepatitis B: Clinical and epidemiological characteristics. Cold Spring Harb Perspect Med, 2014; 4(12): a024935.
Awan Z, Idrees M, Amin I, Butt S, Afzal S, Akbar H, Rehman IU, et al. Pattern and molecular epidemiology of Hepatitis B virus genotypes circulating in Pakistan. Infect Genet Evol, 2010; 10(8): 1242-6.
Nwokediuko SC. Chronic hepatitis B: Management challenges in resource-poor countries. Hepatitis Monthly, 2011; 11(10): 786.
Khan F, Shams S, Qureshi ID, Israr M, Khan H, Sarwar MT, Ilyas M. Hepatitis B virus infection among different sex and age groups in Pakistani Punjab. Virol J, 2011; 13(8): 225.
Wang SH, Chen PJ, Yeh SH. Gender disparity in chronic hepatitis B: Mechanisms of sex hormones. J Gastroenterol Hepatol, 2015; 30(8): 1237-45.
Hayashi H, Beppu T, Shirabe K, Maehara Y, Baba H. Management of thrombocytopenia due to liver cirrhosis: A review. World J Gastroenterol, 2014; 20(10): 2595–2605.
Shimakawa Y, Ndow G, Njie R, Njai HF, Takahashi K, et al. Hepatitis B core-related antigen: An alternative to hepatitis B virus DNA to assess treatment eligibility in Africa. Clin Infect Dis, 2020; 70(7): 1442-1452.
Wong DK, Seto WK, Cheung KS, Chong CK, Huang FY, et al. Hepatitis B virus core-related antigen as a surrogate marker for covalently closed circular DNA. Liver Int, 2017; 37(7): 995-1001.
Perhimpunan Peneliti Hati Indonesia. Konsensus nasional penatalaksanaan hepatitis B. Jakarta, Perhimpunan Peneliti Hati Indonesia, 2017; 8-10.
Sakamoto S, Putalun W, Vimolmangkang S, Phoolcharoen W, Shoyama Y, Tanaka H, Morimoto S. Enzyme-linked immunosorbent assay for the quantitative/qualitative analysis of plant secondary metabolites. J Nat Med, 2018; 72(1): 32-42.
Jia J, Li Y, Wei C, Guo R, Xu H, et al. Factors associated with disease progression and viral replication in patients with chronic hepatitis B virus infection. Exp Ther Med, 2019; 17(6): 4730-4740.
Kent P, Hancock MJ. Interpretation of dichotomous outcomes: sensitivity, specificity, likelihood ratios, and pre-test and post-test probability. J Physiother, 2016; 62(4): 231-3.
Chen P, Xie Q, Lu X, Yu C, Xu K, et al. Serum HBeAg and HBV DNA levels are not always proportional and only high levels of HBeAg most likely correlate with high levels of HBV DNA: A community-based study. Medicine, 2017; 96(33): e7766.
Downloads
Submitted
Accepted
Published
How to Cite
Issue
Section
License
Copyright (c) 2023 INDONESIAN JOURNAL OF CLINICAL PATHOLOGY AND MEDICAL LABORATORY
This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.
